As inflation skyrockets, it seems prices on everything are climbing – from groceries to lumber to airplane tickets. But in Florida, that trend may soon see a reversal when it comes to prescription drugs. On July 8th, Governor DeSantis signed Executive Order 22-164, which seeks to reduce prescription drug prices by promoting price transparency amongst pharmacy benefit managers (PBMs).
"Florida continues to lead the nation in ensuring accountability in the health care industry and in introducing reforms to combat rising prescription costs," Governor DeSantis said in a news release. "This executive order requires accountability and transparency for pharmaceutical middlemen when doing business with the state, thereby reducing the upward pressure on prescription drug costs."
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
